Antibody fragments in radioimmunotherapy (RIT): The role of the radiation dose and dose rate on toxicity and anti-tumor efficacy.

被引：0
|
作者：
Behr, TM
Memtsoudis, S
Sharkey, RM
Blumenthal, RD
Dunn, RM
Goldenberg, DM
Becker, W
机构：
[1] Garden State Canc Ctr, Belleville, NJ USA
[2] Univ Gottingen, Dept Nucl Med, D-3400 Gottingen, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 1998年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
439
引用
收藏
页码：112P / 112P
页数：1
相关论文
共 50 条
  • [1] Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy
    Behr, TM
    Memtsoudis, S
    Sharkey, RM
    Blumenthal, RD
    Dunn, RM
    Gratz, S
    Wieland, E
    Nebendahl, K
    Schmidberger, H
    Goldenberg, DM
    Becker, W
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1998, 77 (05) : 787 - 795
  • [2] The Effects of Radiation Dose Heterogeneity on the Tumor Microenvironment and Anti-Tumor Immunity
    Takashima, Maya E.
    Berg, Tracy J.
    Morris, Zachary S.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2024, 34 (03) : 262 - 271
  • [3] The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity
    Poleszczuk, Jan
    Enderling, Heiko
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [4] A radiation dose response exists for radioimmunotherapy (RIT) of B-cell lymphoma only in the presence of signalling monoclonal antibody (mAb)
    Du, Y
    Honeychurch, J
    Johnson, PWM
    Glennie, MJ
    Illidge, TM
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 : S13 - S14
  • [5] Successful radioimmunotherapy (RIT) of B-cell lymphomas depends on synergy between low dose rate irradiation and antibody (MAB)
    Du, Y
    Honeychurch, J
    Johnson, PWM
    Illidge, TM
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 : 59 - 59
  • [6] An anti-tumor immune response is evoked by partial-volume single dose radiation
    Haimovitz-Friedman, Adriana
    Humm, Johnn
    Deasy, Joseph O.
    Wolchok, Jedd
    Merghoub, Taha
    Russell, James
    Li, Hongyan
    Samstein, Robert
    Budhu, Sadna
    Powell, Simon
    Bodden, Chloe
    Markovsky, Ela
    Chen, Qing
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [7] Magnetic fields enhance the anti-tumor efficacy of low dose cisplatin and reduce the nephrotoxicity
    Monira M. Rageh
    Marwa R. El-Garhy
    Ebtesam A. Mohamad
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2020, 393 : 1475 - 1485
  • [8] Magnetic fields enhance the anti-tumor efficacy of low dose cisplatin and reduce the nephrotoxicity
    Rageh, Monira M.
    El-Garhy, Marwa R.
    Mohamad, Ebtesam A.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (08) : 1475 - 1485
  • [9] Dose dependent pharmacokinetics, tissue distribution, and anti-tumor efficacy of a humanized monoclonal antibody against DLL4 in mice
    Kamath, Amrita V.
    Yip, Victor
    Gupta, Priyanka
    Boswell, C. Andrew
    Bumbaca, Daniela
    Haughney, Peter
    Castro, Joni
    Tsai, Siao Ping
    Pacheco, Glenn
    Ross, Sarajane
    Yan, Minhong
    Damico-Beyer, Lisa A.
    Khawli, Leslie
    Shen, Ben-Quan
    [J]. MABS, 2014, 6 (06) : 1631 - 1637
  • [10] Radiation Dose Rate, Biologically Effective Dose, and Tumor Characteristics on Local Control and Toxicity After Radiosurgery for Acoustic Neuromas
    Villafuerte, Conrad Josef
    Shultz, David B.
    Laperriere, Normand
    Gentili, Fred
    Heaton, Robert
    van Prooijen, Monique
    Cusimano, Michael D.
    Hodaie, Mojgan
    Schwartz, Michael
    Berlin, Alejandro
    Payne, David
    Kalia, Suneil K.
    Bernstein, Mark
    Wang, Justin
    Zadeh, Gelareh
    Spears, Julian
    Tsang, Derek S.
    [J]. WORLD NEUROSURGERY, 2021, 152 : E512 - E522
12345